IT’S THE BUSINESS, STUPID* (LAUNCHING A NEW MEDICINE WITHOUT A FIELD FORCE – FINAL PART)
I hope you had read my two previous blog posts: Launching a new medicine without a field force – Part 1 & Part 2. If you haven’t yet, I encourage you to have a look at them, but after having read this one. The last…
CASE STUDY: LAUNCHING A NEW MEDICINE WITHOUT A FIELD FORCE (PART 2)
Part 1: Launching a new medicine without a field force … Mr Khatri and his steering committee had been analysing the proposal brought to the table by the European Business Development team, but they haven´t reached a conclusion yet. It was obvious that were it…
CASE STUDY: LAUNCHING A NEW MEDICINE WITHOUT A FIELD FORCE (PART 1)
It was four years ago when I had a hard time combining my MBA classes and my full-time job. However, it was an enjoyable experience, and it made me love reflecting on case studies. I learnt a great deal throughout all those semi-real business challenges…
REDES SOCIALES, INDUSTRIA FARMACÉUTICA, SÍ
Llevo un tiempo trabajando en la actualización de la política de uso sobre social media en mi compañía y me vienen muchas ideas sobre lo que se puede y no se puede hacer por parte de la industria farmacéutica en las redes sociales. Porque la…
2019 SPANISH GENERAL ELECTION AND DIGITALISATION IN PHARMA: 3 LESSONS TO LEARN
Dear reader, be aware that this blog post is, once again, about digitalisation and Pharma. To my mind, there are some valuable lessons to learn from the last Spanish general election; however, I’m not by any means dissecting what happened in Spain from a political…
5 razones por las que SÍ creo que tiene sentido tener un blog en 2019
Hace unos días leía una conversación en Twitter sobre el poco alcance que tienen hoy en día los blogs. Si ya nadie comenta en ellos, los lee o se suscribe. Y precisamente porque este año he retomado el blogging junto a mi amigo Javier García,…
NO ALGORITHM, NO GAIN: ENGAGING PRESCRIBERS & DELIVERING BEST-IN-CLASS CUSTOMER EXPERIENCE
Could an algorithm improve the commercial model in Pharma? Launching a new medicine carries much effort and preparation. And yet the moment of truth comes when doctors may prescribe the product. Why is he/she picking out this new medicine instead of any other available option?…
VISITADOR MEDICO DEL FUTURO…segunda parte
Hace dos semanas terminé mi post sobre la visita médica diciendo que tendría una segunda parte, ya que quedaron cosas en el tintero. Y esta segunda parte quiero publicarla hoy. Pero antes, no puedo seguir sin agradecer toda la repercusión que tuvo el post Visitador…
THE PRODUCT MANAGER IS DEAD, LONG LIVE TO THE PRODUCT & CUSTOMER MANAGER!
My colleague in this blog, Javier Télez, wrote an interesting post about the role of medical sales reps. He described their job accurately and emphasised their relevance. Honestly, I can´t disagree with him but, on the other hand, I think sales teams have been covering…
VISITADOR MEDICO DEL FUTURO…VISITADOR MEDICO DEL PASADO
Ya lo he contado antes, pero llevo trabajando en la industria farmacéutica más de 18 años. Empecé de visitador médico, como una manera de estar involucrado dentro de un mundo que siempre me ha apasionado, que es el de la sanidad. Desde niño quise ser…
Stay connected